LCB-2122, CAS [[2210298-14-7]] Preis auf Anfrage

Produktübersicht

• Artikelname: LCB-2122, CAS [[2210298-14-7]] Preis auf Anfrage
• Artikelnummer: MCE-HY-180575
• Hersteller Artikelnummer: HY-180575
• Alternativnummer: MCE-HY-180575-1UNIT
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

LCB-2122 is an adenosine-like nucleoside analogue bearing a C2-stereogenic all-carbon quaternary center. LCB-2122 can prevent Doxorubicin (HY-15142A)-induced cardiomyocytes apoptosis with an IC50 of 0.5 µM and prevent Imatinib (HY-15463)-induced apoptosis. LCB-2122 can activate AMPK signaling and induce the phosphorylation of AMPK and its downstream substrate, acetyl-CoA carboxylase (ACC). LCB-2122 can reduce Doxorubicin-induced mitochondrial damage. LCB-2122 can be used for the research of heart failure[1].

Produkteigenschaften

• Molekulargewicht: 465.83
• CAS Nummer: [2210298-14-7]
• Formel: C16H25ClN5O7P
• Target-Kategorie: Acetyl-CoA Carboxylase,AMPK,Apoptosis,Nucleoside Antimetabolite/Analog

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound